PO.CL01.12 · 临床研究

SPACE: Spatially resolved multiomic analysis for high-throughput CRISPR screening in 3D models

海报缩略图:SPACE: Spatially resolved multiomic analysis for high-throughput CRISPR screening in 3D models
编号 1214 展板 15 时间 4/19 02:00–05:00 区域 Section 47 主讲 Mengwei Hu, PhD
分会场 Spatial Proteomics and Transcriptomics 1
查看完整资料 下载 PDF 登录后可访问当前开放资料 AACR 官方页面 ↗

作者与单位

Mengwei Hu1, Yi Cui2, Qianhui Huang1, Khoi Chu1, Sierra McKinzie2, Michael Patrick2, Sharanya Iyengar1, Maerjianghan Abuduli1, Marianne Spatz1, Nandita Joshi1, Brendan Miller1, Shams Vellarikkal1, Timothy Riordan2, Danny Bitton3, Jan Lubojacky3, Iya Khalil1, Federica Piccioni1, Michael Rhodes2, Alex Tamburino1, Shanshan He2, Joseph Beechem2, Vanessa Peterson1

1Merck & Co., Inc, Cambridge, MA,2Bruker Spatial Biology, Seattle, WA,3MSD, Prague, Czech Republic

摘要 Abstract

High-content single-cell perturbation screens are pivotal for elucidating gene functions and uncovering novel biology, yet conventional methods necessitate cell dissociation, forfeiting critical spatial information essential for dissecting cell-cell interactions and tissue architecture in complex microenvironments. While spatial CRISPR screening mitigates this partially, existing technologies are constrained by hypothesis-driven phenotyping panels limited to sparse RNA or protein coverage, curtailing comprehensive gene function assessment and discovery breadth.To overcome these barriers, we developed SPACE ( SPA tial C ell E xploration), a pioneering platform that fuses whole-transcriptome profiling, CRISPR perturbations, and multiplexed protein detection at single-cell resolution within intact 3D tissue contexts. SPACE delivers unbiased, transcriptome-wide readouts alongside compatibility for up to 76 protein markers, vastly expanding phenotypic landscapes in spatial screens. As the highest-plex multimodal spatial CRISPR assay to date, SPACE achieves this at unprecedented scale and affordability and largely outperforms sequencing-based alternatives in efficiency.We applied SPACE across 42 gene perturbations in cancer-associated fibroblasts (CAFs) co-cultured with tumor cells in 3D spheroids, yielding multidimensional multiomic datasets from hundreds of spheroids. High-confidence guide RNA detection was coupled with robust endogenous mRNA characterization. Unbiased analyses uncovered new insights on CAF-tumor dynamics: extracellular matrix (ECM) remodeling, spatially resolved ligand-receptor interactions, and perturbation-specific gene variability.Notably, ISG20 knockout in CAFs profoundly suppressed multiple matrix metalloproteinases - an unreported link validated orthogonally - implicating ISG20 in novel ECM regulation and tumor progression. Some perturbations were further revealed to reshape intercellular signaling, revealing knockout-dependent spatial ligand-receptor shifts and coordinated expression signatures that underscore microenvironmental crosstalk in tumor phenotypes.Culminating in a landmark demonstration, SPACE simultaneously captured whole transcriptomes, CRISPR identities, and 68 protein markers on one slide, enabling holistic perturbation phenotyping. This transformative technology propels spatial CRISPR screening into translational realms, facilitating target and biomarker identification in multicellular models mirroring human tissue intricacy. By merging high-throughput perturbations with spatially resolved multiomics at transcriptome scale, SPACE catalyzes discovery in heterogeneous tissues. SPACE datasets will fuel generative AI models for causal biology inference, accelerating drug discovery and precision medicine.
利益披露 Disclosure
M. Hu, Merck & Co., Inc Employment. Y. Cui, Bruker Spatial Biology Employment. Q. Huang, Merck & Co., Inc Employment. K. Chu, Merck & Co., Inc Employment. S. McKinzie, Bruker Spatial Biology Employment. M. Patrick, Bruker Spatial Biology Employment. S. Iyengar, Merck & Co., Inc Employment. M. Abuduli, Merck & Co., Inc Employment. M. Spatz, Merck & Co., Inc Employment. N. Joshi, Merck & Co., Inc Employment. B. Miller, Merck & Co., Inc Employment. S. Vellarikkal, Merck & Co., Inc Employment. T. Riordan, Bruker Spatial Biology Employment. D. Bitton, MSD Employment. J. Lubojacky, MSD Employment. I. Khalil, Merck & Co., Inc Employment. F. Piccioni, Merck & Co., Inc Employment. M. Rhodes, Bruker Spatial Biology Employment. A. Tamburino, Merck & Co., Inc Employment. S. He, Bruker Spatial Biology Employment. J. Beechem, Bruker Spatial Biology Employment. V. Peterson, Merck & Co., Inc Employment.

在会议检索中打开